CGON
CG Oncology, Inc.
67.20$
-2.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | -98.2% | +6.8% | +458.3% | +254.7% | |
| – | +50.0% | +304,913.3% | +79.5% | -94.3% | |
| – | -98.3% | -25,979.5% | – | – | |
| – | +58.5% | +57.6% | +79.5% | +42.1% | |
| – | +38.0% | +54.5% | +240.4% | +118.2% | |
| – | +54.3% | -72.0% | +240.4% | +464.2% | |
| – | – | – | – | – | |
| – | -99.8% | +690,300.0% | – | – | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.